|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Application of artificial intelligence in tongue diagnosis of traditional Chinese medicine:A review显示文摘Tongue diagnosis is an important process to non-invasively assess the condition of a patient’s internal organs in traditional Chinese medicine(TCM)and each part of the tongue is related to corresponding internal organs.Due to continuing computer technological advances,especially the artificial intelligence(AI)methods have achieved significant success in tackling tongue image acquisition,processing,and classification,novel AI methods are being introduced in traditional Chinese medicine tongue diagnosis medical practices.Traditional tongue diagnose depends on observations of tongue characteristics,such as color,shape,texture,moisture,etc.by traditional Chinese medicine physicians.The appearance of the tongue color,texture and coating reflects the improvement or deterioration of patient’s conditions.Moreover,AI can now distinguish patient’s condition through tongue images,texture or coating,which is all possible increasingly with help from traditional Chinese medicine physicians under the traditional Chinese medicine tongue theory.AI has enabled humans to do what was previously unimagined:traditional Chinese medicine tongue diagnosis with feeding a large amount of tongue image and tongue texture/coating data to train the AI modes.This review focuses on the research advances of AI in TCM tongue diagnosis thus far to identify the major scientific methods and prospects.In this article,we tried to review the AI application in resolving the tongue diagnosis of traditional Chinese medicine on color correction,tongue image extraction,tongue texture/coating segmentation. | Zhao Chen Xiaoyu Zhang Ruijin Qiu Yang Sun Rui Zheng Haie Pan Yin Jiang Changming Zhong Chen Zhao Guihua Tian Hongcai Shang | 2021 | TMR Modern Herbal Medicine2021，4，2： | 2 |
| 2 | The global registry of COVID-19 clinical trials: indicating the design of traditional Chinese medicine clinical trials显示文摘Objective:To analyze the registration information of Corona Virus Disease 2019(COVID-19)related clinical trials from all the clinical trial registry accepted by the International Committee of Medical Journal Editors(ICMJE).Methods:All the database of ICMJE-accepted clinical trial registry platform were searched for COVID-19 related clinical trials that registered from December 8,2019 to February 19,2020.Results:All the database totally contained data of 209 COVID-19 related clinical trials,including 66(31.6%)traditional Chinese medicine(TCM)related studies and 143(68.4%)non-TCM related studies.176(84.2%)clinical trials were registered in ChiCTR,as 33(15.8%)were registered in ClinicalTrials.gov.There were 152(72.7%)intervention trials,including 9(4.3%in total)preventive trials,136(65.1%in total)therapeutic trials and 7(3.3%in total)convalescent trials.Conclusion:At the present stage,clinical studies are still aiming at exploring the effective treatment of COVID-19,and the existing treatments need more high-quality clinical evidence supporting.Traditional Chinese medicine may have played an important role in all stages of the epidemic preventing and control,and the enthusiasm of carrying out scientific research has also been greatly improved.The relevant policies of clinical trial registration should be popularized among researchers,including traditional Chinese medicine researchers.And the methodological quality of clinical trials’design urges improving. | Xuxu Wei Mengzhu Zhao Chen Zhao Xiaoyu Zhang Ruijin Qiu Yiyi Lin Yang Sun Manke Guan Hongcai Shang | 2020 | TMR Modern Herbal Medicine2020，3，3： | 1 |
| 3 | Synthesis and optical properties of novel apatite-type NaCa_(3)Bi(PO_(4))_(3)F:Dy^(3+)yellow-emitting fluorophosphate phosphors for white LEDs显示文摘In this study,novel yellow-emitting fluorophosphate NaCa_(3)Bi(PO_(4))_(3)F phosphors doped with different concentrations of Dy^(3+)ions were first obtained via high-temperature solid-state reaction.The crystal structure,phase purity,particle morphology,photoluminescence(PL)properties,thermal stability,and luminescence decay curves of the resulting phosphors were then characterized in detail.Under the excitation of 349 nm,the three dominant peaks of the NaCa_(3)Bi(PO_(4))_(3)F:Dy^(3+)are centered at 480 nm(^(4)F_(9/2)-^(6)H_(15/2)),577 nm(^(4)F_(9/2)-^(6)H_(13/2)),and 662 nm(^(4)F_(9/2)-^(6)H_(11/2)).The optimal doping concentration of Dy^(3+)ions in the NaCa_(3)Bi(PO_(4))_(3)F:xDy^(3+)phosphors is x=5 mol%.The phosphors show excellent thermal stability with high activation energy(Ea=0.32 eV).Eventually,the synthesized white lightemitting diode(w-LED)demonstrates the Commission International de L’Eclairage(CIE)chromaticity coordinates of(0.341,0.334),a good correlated color temperature(CCT)of 5083 K,and a high color rendering index(Ra)of 92.Revealing its potential as yellow-emitting phosphors,the feasibility of the fabricated apatite-type NaCa_(3)Bi(PO_(4))_(3)F:Dy^(3+)fluorophosphate phosphors was confirmed for wLEDs. | Yuan Wang Guangliang Lu Yang Qiu Wen Sun Siqi Qin Yifang Lin Bin Deng Dan zhang Ruijin Yu | 2022 | Journal of Rare Earths2022，40，12： | 0 |
| 4 | Smartphone-Based Photoelectrochemical Immunoassay with Co_(9)S_(8)@ZnIn_(2)S_(4) for Point-of-Care Diagnosis of Breast Cancer Biomarker显示文摘Photoelectrochemical immunoassays incorporating specific antigen-antibody recognition reactions with the photon-electron conversion capabilities of photocatalysts have been developed for biomarker detection,but most involve bulky and expensive equipment and are unsuitable for point-of-care testing. | Ruijin Zeng Yuxuan Li Yanli Li Qing Wan Zhisheng Huang Zhenli Qiu Dianping Tang | 2023 | Research2023，，2： | 0 |
| 5 | Wenxin granule for cardiac arrhythmia: an overview of systematic reviews显示文摘目的:对稳心颗粒治疗心律失常的系统评价/meta分析进行再评价,为临床应用提供证据;分析目前研究中存在的问题,为研究者提供可能的优先研究主题。方法:从8 个数据库中检索稳心颗粒治疗心律失常的系统评价。分别用AMSTAR和GRADE评估系统评价的方法学质量和证据质量。结果:共纳入1 9 项系统评价,涉及52, 9 0 5 个参与者。AMSTAR评分3-10分,平均6 .5 分,中位数为6 分, 9 (9/19, 47.37°%)项系统评价的AMSTAR得分大于7 分,对其中的6 项研究采用GRADE评估其证据质量。结果显示,所有研究的证据质量都在极低和低之间,无中、高质量证存在。从结局指标报告来看,没有系统评价评估终点指标,虽然有部分研究报告了不良反应/事件,但很少有研究进行因果关系判断。系统评价结局指标矩阵显示,结局指标报告存在明显的异质性及不完全报告的情况,导致有些研究不能进行m eta分析。同时,一些原始研究由于结局指标报告不合理而被不能纳入系统评价(如未报告相关结局指标,治疗时间不合适/不清楚,数据不完全或无法提取)。结论:稳心颗粒治疗心律失常的疗效和安全性证据有限,未来需要更多的高质量R C T s和系统评价提供证据。在未来的研究中,有必要构建心律失常核心指标集,以提高结局指标报告水平,减少由于结局指标报告不合理而造成的浪费。 | Ruijin Qiu Changming Zhong Huichan Yuan Xiaoyi Tang Ya Huang Tianmai He Songjie Han Manke Guan Min Li Jiayuan Hu Xiaoyu Zhang Jing Chen Hongcai Shang | 2019 | TMR Modern Herbal Medicine2019，2，2： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员